Agrawal, Nishant
The University of Chicago,
United States
2025 Rank: 51809
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 1559 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51809 | 54931 |
| Total Cites | 2600 | 2886 |
| H-index | 23 | 23 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 358 | 377 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 442 | 461 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2293 | 2503 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
9.91%
|
|
Agrawal, Nishant
The University of Chicago,
United States
2024 Rank: 46086
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 1478 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46086 | 52561 |
| Total Cites | 2663 | 2973 |
| H-index | 22 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 336 | 353 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 468 | 492 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2303 | 2525 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
10.43%
|
|
Agrawal, Nishant
Pritzker School of Medicine,
United States
2023 Rank: 69013
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 69 out of 47021 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69013 | 75320 |
| Total Cites | 1919 | 2031 |
| H-index | 16 | 17 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 386 | 412 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 496 | 530 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1656 | 1728 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
5.51%
|
|
Agrawal, Nishant
The University of Chicago,
United States
2022 Rank: 55932
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 2121 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55932 | 62464 |
| Total Cites | 2111 | 2270 |
| H-index | 18 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 409 | 434 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 535 | 574 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1782 | 1891 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.20 |
| Self-Citation Percentage |
7.00%
|
|
Agrawal, Nishant
The University of Chicago,
United States
2021 Rank: 59881
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 65 out of 43138 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59881 | 66707 |
| Total Cites | 3104 | 3321 |
| H-index | 22 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 584 | 627 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 760 | 820 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2677 | 2832 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.17 |
| Self-Citation Percentage |
6.53%
|
|
Agrawal, Nishant
The University of Chicago,
United States
2020 Rank: 57045
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Otorhinolaryngology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 66 out of 33662 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57045 | 60683 |
| Total Cites | 2379 | 2560 |
| H-index | 18 | 18 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 443 | 490 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 570 | 624 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1989 | 2115 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.21 |
| Self-Citation Percentage |
7.07%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.